Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Total Liabilities (2020 - 2025)

BioAtla (BCAB) has 6 years of Total Liabilities data on record, last reported at $47.1 million in Q3 2025.

  • For Q3 2025, Total Liabilities rose 20.06% year-over-year to $47.1 million; the TTM value through Sep 2025 reached $47.1 million, up 20.06%, while the annual FY2024 figure was $38.2 million, 22.11% down from the prior year.
  • Total Liabilities reached $47.1 million in Q3 2025 per BCAB's latest filing, up from $43.9 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $56.7 million in Q3 2023 and bottomed at $33.2 million in Q1 2021.
  • Average Total Liabilities over 5 years is $44.0 million, with a median of $43.9 million recorded in 2025.
  • Peak YoY movement for Total Liabilities: tumbled 42.43% in 2021, then rose 25.49% in 2022.
  • A 5-year view of Total Liabilities shows it stood at $43.6 million in 2021, then grew by 4.12% to $45.4 million in 2022, then rose by 7.91% to $49.0 million in 2023, then dropped by 22.11% to $38.2 million in 2024, then grew by 23.56% to $47.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $47.1 million in Q3 2025, $43.9 million in Q2 2025, and $37.7 million in Q1 2025.